GLP 1 RECEPTOR AGONISTS
GLP-1 receptor agonists: a review of headto-head
... the GLP-1 RA agents are administered as subcutaneous (SC) ...the GLP-1 RA class are gastrointesti- nal (GI) related (nausea, vomiting, and diarrhea) and injection-site ...four ...
10
GLP 1 receptor agonists for Parkinson's disease (Protocol)
... of GLP-1 receptor agonists for PD, as this will provide a summary of the current state of the evidence, as well as providing a platform for updating the evidence base as future studies ...
14
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
... all GLP-1 receptor agonists affect both the basal and prandial com- ponents of hyperglycemia in patients with type 2 diabe- tes, although the main mechanism by which they reduce postprandial ...
9
Emerging role of GLP-1 receptor agonists in the treatment of obesity
... hormone, GLP-1, also plays an important role in glucose homeostasis. GLP-1 receptor agonists, such as exenatide and liraglutide, have been developed and are already approved for ...
11
Role and development of GLP-1 receptor agonists in the management of diabetes
... GLP-1 receptor agonists and diabetes management Dovepress The development of GLP-1R agonists started with their potential as insulin ...of GLP-1 and GLP-1R ...
13
GLP 1 receptor agonists show neuroprotective effects in animal models of diabetes
... with GLP-1 receptor agonists improved neuronal growth and repair and reduced inflammation and apoptosis as well as oxidative ...metformin, GLP-1 receptor agonists ...
20
Extra Glycemic Impacts of GLP 1 Receptor Agonists: Benefits of a Class Effect?
... and GLP-1 has been demonstrated in experiments in rodents showing that subthreshold doses of leptin increased the ability of GLP-1 inhibit food ...more, GLP-1 receptor ...
15
The GLP 1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK dependent mechanism
... Results Glp‑1 receptor expression in different species and tissues EXE, as well as other GLP-1 receptor agonists, exert their function by binding to the ...whether ...
13
Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
... Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence Timothy Reid, MD T he management of patients with type 2 diabetes has become more complex in recent ...
10
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review 68:20.06 Incretin Mimetics
... A GLP-1 receptor agonist may be added to a patients regimen if metformin monotherapy is contraindicated, not tolerated or does not achieve the target A1C at 3-6 ...(GLP-1) ...
22
Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists
... a GLP-1 receptor agonist or DPP-4 inhibitor (or a thiazolidinedione [TZD]) is recommended by the ADA/EASD because of their low risk of ...metformin, GLP-1 receptor ...
12
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
... for GLP-1 RAs in T2DM significantly by sex, with a strong preference for the profile representing dulaglutide among patients of both ...Typically GLP-1 receptor agonists are the ...
12
<p>Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data</p>
... (GLP-1) receptor agonists have been available as glu- cose-lowering therapies for people with type 2 diabetes since 2006, when twice-daily exenatide was ...” GLP-1 ...
6
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
... detect GLP-1R protein in ventricular cardiomyocytes leaded to the revaluation of those earlier ...available GLP-1R antisera detected multiple nonspecific immunoreactive proteins even in tissue extracts from ...
11
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
... peptide-1 receptor (GLP-1r) agonists, now greatly prescribed for the treatment of T2DM, have beneficial skeletal effects although the underlying mechanisms are not completely ...of ...
24
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
... to GLP-1RA and SGLT2-I over older medication classes including SU and ...classes, GLP-1RA and SGLT2-I, in particular show promise as second-line treat- ment options given their favorable effects on weight ...
11
The effect of glucagon like peptide 1 (GLP 1) receptor agonists on cell viability, ADAM10 maturation and the proteolysis of ADAM10 substrates in SH SY5Y cells
... 1.9. Summary. It is clear from the literature that GLP-1 agonists, including Exendin-4 and Liraglutide, exhibit neuroprotective effects. Their ability to combat oxidative damage and ...
109
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
... Study limitations and strength This study has limitations related to its retrospective non-randomized design. Patients who initiate GLP-1RA or DPP-4i typically differ in many clinical characteris- tics and the ...
12
Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
... through GLP-1 RAs may lead to improved patient outcomes beyond glycemic ...Therefore, GLP-1 RAs are ranked hierarchically first before other options in this ...
12
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study
... of GLP‑1ra to a broad spectrum of real‑world T2D patients using ...Keywords: GLP‑1 receptor agonist, Cardiovascular safety, DPP‑4 inhibitor, Sulfonylurea, Insulin © The Author(s) ...
10